Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk inwomen with breast cancer

JAMA Surgery

Volumn 149, Issue 8, 2014, Pages 788-796

  Black, Dalliah M ^a   Jiang, Jing ^a   Kuerer, Henry M ^a   Buchholz, Thomas A ^a   Smith, Benjamin D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER STAGING; CHARLSON COMORBIDITY INDEX; FEMALE; HUMAN; HUMAN TISSUE; LYMPHEDEMA; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME; VERY ELDERLY;

AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HUMANS; LYMPHEDEMA; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SEER PROGRAM; SENTINEL LYMPH NODE BIOPSY; SOCIOECONOMIC FACTORS;

EID: 84906691025     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2014.23     Document Type: Article

References (30)

1. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220(3):391-401.
2. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349(6):546-553.
3. Krag D,Weaver D, Ashikaga T, et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med. 1998;339(14):941-946.
4. Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10): 927-933.
5. Veronesi U, Viale G, Paganelli G, et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg. 2010;251(4):595-600.
6. American Society of Breast Surgeons. Guidelines for performing sentinel lymph node biopsy in breast cancer. https://www.breastsurgeons.org/statements/ 2010-Nov-05-Guidelines-on-Performing-SLN.pdf. Accessed July 26, 2013.
7. Anderson BO. Sentinel lymphadenectomy in breast cancer: an update on the NCCN clinical practice guidelines. J Natl Compr Canc Netw. 2003;1 (suppl 1):S64-S70.
8. American Society of Breast Surgeons. Guidelines for performing sentinel lymph node biopsy in breast cancer. 2nd rev. Columbia, MD: American Society of Breast Surgeons; 2002.
9. Goldhirsch A,Wood WC, Gelber RD, Coates AS, Thürlimann B, Senn HJ. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol. 2003;21(17):3357-3365.
10. Lyman GH, Giuliano AE, SomerfieldMR, et al; American Society of Clinical Oncology. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23 (30):7703-7720.
11. NCCN clinical practice guidelines in oncology. https://www.nccn.org/ store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/ physician-gls/pdf/breast.pdf. Accessed September 6, 2013.
12. Carpenter WR, Reeder-Hayes K, Bainbridge J, et al. The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation. Med Care. 2011;49(2):172-179.
13. Chen AY, HalpernMT, Schrag NM, Stewart A, LeitchM,Ward E. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005). J Natl Cancer Inst. 2008;100(7):462-474.
14. MaggardMA, Lane KE, O'Connell JB, Nanyakkara DD, Ko CY. Beyond the clinical trials: how often is sentinel lymph node dissection performed for breast cancer? Ann Surg Oncol. 2005;12(1):41-47.
15. American College of Surgeons. Coding cancer registry items: scope of regional lymph node surgery: a review of data validity, revised coding directives, and agency transition plans. http://www.facs.org/cancer/ncdb/scope- regional-lymph-node-surgery.pdf. Accessed August 22, 2013.
16. Zaslavsky AM, Ayanian JZ, Zaborski LB. The validity of race and ethnicity in enrollment data for Medicare beneficiaries. Health Serv Res. 2012;47(3, pt 2):1300-1321.
17. Klabunde CN, Potosky AL, Legler JM,Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53 (12):1258-1267.
18. Keating NL, Kouri E, He Y,Weeks JC, Winer EP. Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery? Med Care. 2009;47(7):765-773.
19. Beaulac SM, McNair LA, Scott TE, LaMorte WW, Kavanah MT. Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg. 2002;137(11):1253-1257.
20. Sener SF,Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer. 2001;92(4):748-752.
21. Langer I, Guller U, Berclaz G, et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg. 2007; 245(3):452-461.
22. Golshan M, MartinWJ, Dowlatshahi K. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg. 2003;69(3):209-212.
23. Lucci A, McCall LM, Beitsch PD, et al; American College of Surgeons Oncology Group. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007;25(24):3657-3663.
24. Meric F, Buchholz TA, Mirza NQ, et al. Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol. 2002;9(6):543-549.
25. Ashikaga T, Krag DN, Land SR, et al; National Surgical Adjuvant Breast, Bowel Project. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010;102(2):111-118.
26. Shih YC, Xu Y, Cormier JN, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27(12): 2007-2014.
27. Lantz PM, MujahidM, Schwartz K, et al. The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis. Am J Public Health. 2006;96(12):2173-2178.
28. Warner ET, Tamimi RM, HughesME, et al. Time to diagnosis and breast cancer stage by race/ethnicity. Breast Cancer Res Treat. 2012;136(3): 813-821.
29. Ooi SL, Martinez ME, Li CI. Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat. 2011;127(3): 729-738.
30. Martelli G, Boracchi P, Ardoino I, et al. Axillary dissection versus no axillary dissection in older patients with T1N0 breast cancer: 15-year results of a randomized controlled trial. Ann Surg. 2012;256 (6):920-924.